Kyowa Kirin Co. Ltd
Kyowa Kirin Co., Ltd. engages in the research, development, manufacture, import/export, and market of pharmaceuticals products worldwide. The company offers Crysvita, a recombinant human monoclonal IgG1 antibody against the phosphaturic hormone fibroblast growth factor 23; POTELIGEO for the treatment of cutaneous T-cell lymphoma; Nouriast/Nourianz, an adenosine A2A receptor antagonist; G-LASTA, a… Read more
Kyowa Kirin Co. Ltd (KYKOF) - Total Assets
Latest total assets as of December 2025: $1.11 Trillion USD
Based on the latest financial reports, Kyowa Kirin Co. Ltd (KYKOF) holds total assets worth $1.11 Trillion USD as of December 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Kyowa Kirin Co. Ltd - Total Assets Trend (1999–2025)
This chart illustrates how Kyowa Kirin Co. Ltd’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Kyowa Kirin Co. Ltd - Asset Composition Analysis
Current Asset Composition (December 2025)
Kyowa Kirin Co. Ltd's total assets of $1.11 Trillion consist of 44.5% current assets and 55.5% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 19.8% |
| Accounts Receivable | $181.36 Billion | 16.4% |
| Inventory | $67.50 Billion | 6.1% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $201.59 Billion | 18.2% |
| Goodwill | $183.66 Billion | 16.6% |
Asset Composition Trend (1999–2025)
This chart illustrates how Kyowa Kirin Co. Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Kyowa Kirin Co. Ltd's current assets represent 44.5% of total assets in 2025, a decrease from 51.5% in 1999.
- Cash Position: Cash and equivalents constituted 19.8% of total assets in 2025, up from 2.3% in 1999.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 34.0% of total assets, an increase from 32.0% in 1999.
- Asset Diversification: The largest asset category is intangible assets at 18.2% of total assets.
Kyowa Kirin Co. Ltd Competitors by Total Assets
Key competitors of Kyowa Kirin Co. Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Swedish Orphan Biovitrum AB (publ)
PINK:BIOVF
|
USA | $67.26 Billion |
|
Kamada
NASDAQ:KMDA
|
USA | $378.79 Million |
|
One World Pharma Inc
OTCQB:OWPC
|
USA | $6.62 Million |
|
Dongwha Pharm.Co.Ltd
KO:000020
|
Korea | ₩654.63 Billion |
|
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078
|
China | CN¥27.28 Billion |
|
Yuhan Corp.
KO:000100
|
Korea | ₩3.05 Trillion |
|
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153
|
China | CN¥4.97 Billion |
|
Kotra Industries Bhd
KLSE:0002
|
Malaysia | RM363.90 Million |
Kyowa Kirin Co. Ltd - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Moderate asset utilization - Kyowa Kirin Co. Ltd generates 0.45x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Solid ROA - For every $100 in assets, Kyowa Kirin Co. Ltd generates $6.05 in net profit.
Kyowa Kirin Co. Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.72 | 3.06 | 5.59 |
| Quick Ratio | 2.35 | 2.62 | 4.90 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $312.54 Billion | $ 339.35 Billion | $ 363.75 Billion |
Kyowa Kirin Co. Ltd - Advanced Valuation Insights
This section examines the relationship between Kyowa Kirin Co. Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.15 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | 3.9% |
| Total Assets | $1.11 Trillion |
| Market Capitalization | $3.46 Billion USD |
Valuation Analysis
Below Book Valuation: The market values Kyowa Kirin Co. Ltd's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Kyowa Kirin Co. Ltd's assets grew by 3.9% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Kyowa Kirin Co. Ltd (1999–2025)
The table below shows the annual total assets of Kyowa Kirin Co. Ltd from 1999 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | $1.11 Trillion | +3.88% |
| 2024-12-31 | $1.07 Trillion | +4.04% |
| 2023-12-31 | $1.03 Trillion | +9.16% |
| 2022-12-31 | $939.88 Billion | +1.95% |
| 2021-12-31 | $921.87 Billion | +15.05% |
| 2020-12-31 | $801.29 Billion | +2.15% |
| 2019-12-31 | $784.45 Billion | +5.72% |
| 2018-12-31 | $741.98 Billion | +4.76% |
| 2017-12-31 | $708.29 Billion | +1.60% |
| 2016-12-31 | $697.17 Billion | -3.27% |
| 2015-12-31 | $720.76 Billion | +0.23% |
| 2014-12-31 | $719.13 Billion | -0.02% |
| 2013-12-31 | $719.25 Billion | +5.88% |
| 2012-12-31 | $679.34 Billion | +3.11% |
| 2011-12-31 | $658.87 Billion | -5.32% |
| 2010-12-31 | $695.86 Billion | +0.09% |
| 2009-12-31 | $695.27 Billion | +76.43% |
| 2007-12-31 | $394.08 Billion | +4.01% |
| 2006-12-31 | $378.87 Billion | -1.43% |
| 2005-12-31 | $384.38 Billion | +2.64% |
| 2004-12-31 | $374.49 Billion | +3.71% |
| 2003-12-31 | $361.10 Billion | -2.08% |
| 2002-12-31 | $368.77 Billion | -14.26% |
| 2001-12-31 | $430.11 Billion | -0.30% |
| 2000-12-31 | $431.41 Billion | -0.59% |
| 1999-12-31 | $433.96 Billion | -- |